Home›Search›Frontiers in Anti-infective Drug Discovery

Frontiers in Anti-infective Drug Discovery

Bentham Science Publishers · United Arab Emirates · Est. 2018

ISSN2451-9162

SJR Q4✓ Scopus / SJR

/ 100

Established

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ Scopus Q446

Total46

Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

Publication speed: not measurable

publisher doesn’t disclose per-article submission dates — we never estimate

SJR Rank

Bottom 25%

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals.

SJR Scorei

0.133

H-Indexi

Total Worksi

Total Citationsi

2yr Mean Citednessi

0.25

Open Impact Factor alternative

Aims & Scope

Subject areas: Drug Discovery; Infectious Diseases; Molecular Medicine.

General Information

Country / RegionUnited Arab Emirates

Primary Language—

1st Year Published2018

Annual Volume~ 9 articles / year

StatusActive (last: 2024)

Total Publications40

Publisher OrgBentham Science Publishers

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

4/12 · 33%

✅

Do you know the journal / publisher?

Bentham Science Publishers

❌

Does the journal have a website?

No URL

✅

Is the ISSN verified?

2451-9162

✅

Indexed in a trusted database?

Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

❌

Primary language documented?

N/A

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

2018

2019

2020

2021

2024

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Drug DiscoveryQ4

Infectious DiseasesQ4

Molecular MedicineQ4

Subject Classification

Scopus Categories

Drug DiscoveryInfectious DiseasesMolecular Medicine

Research Topics (OpenAlex)

Computational Drug Discovery MethodsBiosimilars and Bioanalytical MethodsLegal Cases and CommentaryDiverse Scientific and Economic StudiesHuman auditory perception and evaluationBacteriophages and microbial interactionsAntibiotic Resistance in BacteriaMosquito-borne diseases and controlMicrobial Natural Products and BiosynthesisSynthesis and biological activity

Frequently asked questions about Frontiers in Anti-infective Drug Discovery

Is Frontiers in Anti-infective Drug Discovery a predatory journal?

PubScope has no integrity flags on record for Frontiers in Anti-infective Drug Discovery: it is indexed in Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 46/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Frontiers in Anti-infective Drug Discovery?

Frontiers in Anti-infective Drug Discovery is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.133.

Is Frontiers in Anti-infective Drug Discovery indexed in Scopus and Web of Science?

Frontiers in Anti-infective Drug Discovery is indexed in Scopus.

What is the aims and scope of Frontiers in Anti-infective Drug Discovery?